Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by lscfaon Dec 18, 2021 8:26am
310 Views
Post# 34243119

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2022 reimbursement rates

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2022 reimbursement rates

Try looking beyond a qtr or two, you short-sighted dimwit. The whole industry is experiencing 5% organic growth due to demographic trends (increasing no.s of 65+ seniors). Even if there was no organic growth a consolidater increases value by getting rid of duplicate costs.  



Carlito3311 wrote: lscfa, you sound desperate...the stock price is telling you everything.  zero to negative organic growth in Q4.  Go back to the Q3 financials and look how they stuffed the June 23rd acquisitions revenue numbers in Q3 to bolster numbers...well above the pro rata rate.  Acquisitions used to cover up a no growth to negative growth base business.



 

<< Previous
Bullboard Posts
Next >>